Gender-Affirming Care for Minors: Lifesaving or Child Abuse?
The battle over puberty blockers and gender surgery for teens has become the culture war’s most toxic minefield. Medical associations versus conservative lawmakers, trans rights versus parental rights. Every hearing devolves into chaos, and every post ignites a thousand angry replies.
Evidence (4)
A peer-reviewed study published in the journal *JAMA Network Open* analyzed data from over 18,000 transgender and nonbinary adolescents. It found that those who received puberty blockers or gender-affirming hormones had a 60% lower odds of past-year suicide attempts compared to those who desired but did not receive such care. The study controlled for depression, family support, and other factors, reinforcing the protective effect of timely, medically supervised treatment.
In a policy statement updated in 2023, the American Academy of Pediatrics (AAP) explicitly endorsed gender-affirming care for minors, including puberty blockers, as safe, effective, and medically necessary. The AAP cited systematic reviews showing improved mental health outcomes and reduced suicidality, and emphasized that delaying care increases distress and self-harm risk. The statement was co-signed by 24 major medical organizations, including the Endocrine Society and the American Medical Association.
The final report of the UK's independent Cass Review, commissioned by NHS England, concluded that the evidence supporting puberty blockers and gender-affirming hormones for minors is 'remarkably weak.' The review, which analyzed over 100 studies, found no high-quality long-term data on mental health or suicide outcomes. It noted that most children treated had co-occurring mental health conditions, and that puberty blockers may impair bone density and brain development. The report recommended extreme caution and a shift toward psychotherapy-first approaches.
Sweden's National Board of Health and Welfare (Socialstyrelsen) and inland's Council for Choices in Health Care (COHERE) both issued updated guidelines in 2021–2022 restricting puberty blockers and hormones for minors to exceptional, research-based cases. Their reviews found that the benefits of these treatments on mental health and suicidality were unproven, while risks included reduced bone density, impaired fertility, and unknown long-term effects. Both countries now prioritize psychological support as first-line care for gender-dysphoric youth.
💬 Comments (0)
登录后参与讨论,赚取 VS币 和荣誉值!
🪙 登录领VS币
💭
No comments yet. Be the first to share!